Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance

Journal: Nature Communications

Published: 2018-02-08

DOI: 10.1038/s41467-018-02915-8

Affiliations: 12

Authors: 13

Go to article
Institutions FC
OSU Department of Chemistry and Biochemistry, United States of America (USA) 0.15
Department of Mechanical and Aerospace Engineering, UVA, United States of America (USA) 0.15
OSU Dorothy M. Davis Heart and Lung Research Institute, United States of America (USA) 0.15
OSU Department of Biomedical Engineering (BME), United States of America (USA) 0.12
OSU Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), United States of America (USA) 0.08
Institute of Digestive Diseases (IDD), SHUTCM, China 0.08
Division of Cardiovascular Medicine, Mizzou, United States of America (USA) 0.06
Center for Precision Medicine, Mizzou, United States of America (USA) 0.06
OSU Division of Hematology, United States of America (USA) 0.04
Department of Medical and Molecular Genetics, IUPUI, United States of America (USA) 0.04
Melvin and Bren Simon Cancer Center (IUSCC), IUPUI, United States of America (USA) 0.04
Fischell Department of Bioengineering, UMCP, United States of America (USA) 0.02

Return